Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia

por Wiatrowski, Kyle, Kim, Tae Hee, Przespolewski, Amanda
Publicado 2022

Predictors of vascular disease in myelodysplastic syndromes

por Faber, Mark G., Lloyd, David R., Singh, Abhay, Baron, Jeffrey, Przespolewski, Amanda, Griffiths, Elizabeth A., Wang, Eunice S., Thota, Swapna
Publicado 2020

Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States

por Singh, Abhay, Herr, Megan M., Griffiths, Elizabeth A., Przespolewski, Amanda, Faber, Mark G., Mrad, Chebli, Wang, Eunice S., Hahn, Theresa, Thota, Swapna
Publicado 2021

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

por Awada, Hassan, Abdelmalek, Mina, Cronin, Tara, Baron, Jeffrey, Kashour, Zakariya, Azad, Farhan, Faisal, Muhammad Salman, Faber, Mark, Gravina, Matthew, Sung, Pamela J., Green, Steven D., Przespolewski, Amanda, Thompson, James E., Griffiths, Elizabeth A., Wang, Eunice S.
Publicado 2023